262 related articles for article (PubMed ID: 29715575)
1. Advances in therapeutic targeting of the DNA damage response in cancer.
Desai A; Yan Y; Gerson SL
DNA Repair (Amst); 2018; 66-67():24-29. PubMed ID: 29715575
[TBL] [Abstract][Full Text] [Related]
2. DNA repair targeted therapy: The past or future of cancer treatment?
Gavande NS; VanderVere-Carozza PS; Hinshaw HD; Jalal SI; Sears CR; Pawelczak KS; Turchi JJ
Pharmacol Ther; 2016 Apr; 160():65-83. PubMed ID: 26896565
[TBL] [Abstract][Full Text] [Related]
3. DNA damage response and repair in pancreatic cancer development and therapy.
Rahnamay Farnood P; Danesh Pazhooh R; Asemi Z; Yousefi B
DNA Repair (Amst); 2021 Jul; 103():103116. PubMed ID: 33882393
[TBL] [Abstract][Full Text] [Related]
4. The role of DNA damage response in chemo- and radio-resistance of cancer cells: Can DDR inhibitors sole the problem?
Sadoughi F; Mirsafaei L; Dana PM; Hallajzadeh J; Asemi Z; Mansournia MA; Montazer M; Hosseinpour M; Yousefi B
DNA Repair (Amst); 2021 May; 101():103074. PubMed ID: 33640757
[TBL] [Abstract][Full Text] [Related]
5. DNA Double Strand Breaks Repair Inhibitors: Relevance as Potential New Anticancer Therapeutics.
Kopa P; Macieja A; Galita G; Witczak ZJ; Poplawski T
Curr Med Chem; 2019; 26(8):1483-1493. PubMed ID: 29446719
[TBL] [Abstract][Full Text] [Related]
6. DNA repair pathways and their implication in cancer treatment.
Pallis AG; Karamouzis MV
Cancer Metastasis Rev; 2010 Dec; 29(4):677-85. PubMed ID: 20821251
[TBL] [Abstract][Full Text] [Related]
7. Targeting BER enzymes in cancer therapy.
Visnes T; Grube M; Hanna BMF; Benitez-Buelga C; Cázares-Körner A; Helleday T
DNA Repair (Amst); 2018 Nov; 71():118-126. PubMed ID: 30228084
[TBL] [Abstract][Full Text] [Related]
8. Understanding DNA damage response and DNA repair pathways: applications to more targeted cancer therapeutics.
Kinsella TJ
Semin Oncol; 2009 Apr; 36(2 Suppl 1):S42-51. PubMed ID: 19393835
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in Therapeutic Application of DNA Damage Response Inhibitors against Cancer.
Fernandes SG; Shah P; Khattar E
Anticancer Agents Med Chem; 2022; 22(3):469-484. PubMed ID: 34102988
[TBL] [Abstract][Full Text] [Related]
10. Breaking the DNA Damage Response via Serine/Threonine Kinase Inhibitors to Improve Cancer Treatment.
Rozpędek W; Pytel D; Nowak-Zduńczyk A; Lewko D; Wojtczak R; Diehl JA; Majsterek I
Curr Med Chem; 2019; 26(8):1425-1445. PubMed ID: 29345572
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs, DNA Damage Response, and Cancer Treatment.
He M; Zhou W; Li C; Guo M
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27973455
[TBL] [Abstract][Full Text] [Related]
12. Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer Therapies.
Davalli P; Marverti G; Lauriola A; D'Arca D
Oxid Med Cell Longev; 2018; 2018():2389523. PubMed ID: 29770165
[TBL] [Abstract][Full Text] [Related]
13. Targeting the DNA Damage Response in Cancer.
O'Connor MJ
Mol Cell; 2015 Nov; 60(4):547-60. PubMed ID: 26590714
[TBL] [Abstract][Full Text] [Related]
14. Initiation of the ATM-Chk2 DNA damage response through the base excision repair pathway.
Chou WC; Hu LY; Hsiung CN; Shen CY
Carcinogenesis; 2015 Aug; 36(8):832-40. PubMed ID: 26025911
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of DNA double-strand break repair at the crossroads of cancer therapy and genome editing.
Ray U; Raghavan SC
Biochem Pharmacol; 2020 Dec; 182():114195. PubMed ID: 32798465
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Targeting of DNA Damage Response in Cancer.
Choi W; Lee ES
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163621
[TBL] [Abstract][Full Text] [Related]
17. DNA damage response regulation by microRNAs as a therapeutic target in cancer.
Majidinia M; Yousefi B
DNA Repair (Amst); 2016 Nov; 47():1-11. PubMed ID: 27697364
[TBL] [Abstract][Full Text] [Related]
18. DNA damage repair and response proteins as targets for cancer therapy.
Lieberman HB
Curr Med Chem; 2008; 15(4):360-7. PubMed ID: 18288990
[TBL] [Abstract][Full Text] [Related]
19. Impaired DNA damage response--an Achilles' heel sensitizing cancer to chemotherapy and radiotherapy.
Darzynkiewicz Z; Traganos F; Wlodkowic D
Eur J Pharmacol; 2009 Dec; 625(1-3):143-50. PubMed ID: 19836377
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between translesion synthesis, Fanconi anemia network, and homologous recombination repair pathways in interstrand DNA crosslink repair and development of chemoresistance.
Haynes B; Saadat N; Myung B; Shekhar MP
Mutat Res Rev Mutat Res; 2015; 763():258-66. PubMed ID: 25795124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]